Nils Ole Dalby

Nils Ole Dalby

Auto-generated profile, based on publicly available information

Nils Ole Dalby

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Current Opinion in Neurology
Verified
Journal Article
Closed access
NDNils Ole Dalby
Nils Ole Dalby
IMIstvan Mody
Istvan Mody
Several recent advances have contributed to our understanding of the processes associated with mesial temporal lobe epilepsy in humans and in experimental animal models. Common pathological features between the human condition and the animal models may indicate a fundamental involvement of the given pathology in the process of epileptogenesis.


1 October 2003 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NDNils Ole Dalby
Nils Ole Dalby

1 October 1995 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SNS Nielsen
S Nielsen
DMD Marples
D Marples
HBHenrik Birn
Henrik Birn
MMM Mohtashami
M Mohtashami
NDN O Dalby
N O Dalby
MKM Knepper
M Knepper
Body water balance is controlled by vasopressin, which regulates Aquaporin-2 (AQP2) water channels in kidney collecting duct cells by vesicular trafficking between intracellular vesicles and the plasma membrane. To examine the molecular apparatus involved in vesicle trafficking and vasopressin regulation of AQP2 in collecting duct cells, we tested if targeting proteins expressed in the synaptic vesicles, namely vesicle-associated membrane proteins 1 and 2 (VAMP1 and 2), are expressed in kidney collecting duct. Immunoblotting revealed specific labeling of VAMP2 (18-kD band) but not VAMP1 in membrane fractions prepared from kidney inner medulla. Controls using preadsorbed antibody or preimmune serum were negative. Bands of identical molecular size were detected in immunoblots of brain membrane vesicles and purified synaptic vesicles. VAMP2 in kidney membranes was cleaved by tetanus toxin, revealing a tetanus toxin-sensitive VAMP homologue. Similarly, tetanus toxin cleaved VAMP2 in synaptic vesicles. In kidney inner medulla, VAMP2 was predominantly expressed in the membrane fraction enriched for intracellular vesicles, with little or no VAMP2 in the plasma membrane enriched fraction. This was confirmed by immunocytochemistry using semithin cryosections, which showed mainly vesicular labeling in collecting duct principal cells, with no labeling of intercalated cells. VAMP2 immunolabeling colocalized with AQP2 labeling in intracellular vesicles, as determined by immunoelectron microscopy after double immunolabeling of isolated vesicles. Quantitative analysis of 1,310 vesicles revealed a highly significant association of both AQP2 and VAMP2 in the same vesicles (P < 0.0001). Furthermore, the presence of AQP2 in vesicles immunoisolated with anti-VAMP2 antibodies was confirmed by immunoblotting. In conclusion, VAMP2, a component of the neuronal SNARE complex, is expressed in vesicles carrying AQP2, suggesting a role in vasopressin-regulated vesicle trafficking of AQP2 water channels.

1 July 1997 in Epilepsy Research
Verified
Journal Article
Closed access
NDNils Ole Dalby
Nils Ole Dalby
ENErik B Nielsen
Erik B Nielsen

1 August 2003 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
NDNils Ole Dalby
Nils Ole Dalby
IMIstvan Mody
Istvan Mody
Activation of N-methyl-d-aspartate (NMDA) receptors by synaptically released glutamate in the nervous system is usually studied using evoked events mediated by a complex mixture of AMPA, kainate, and NMDA receptors. Here we have characterized pharmacologically isolated spontaneous NMDA receptor-mediated synaptic events and compared them to stimulus evoked excitatory postsynaptic currents (EPSCs) in the same cell to distinguish between various modes of activation of NMDA receptors. Spontaneous NMDA receptor-mediated EPSCs recorded at 34°C in dentate gyrus granule cells (DGGC) have a frequency of 2.5 ± 0.3 Hz and an average peak amplitude of 13.2 ± 0.8 pA, a 10–90% rise time of 5.4 ± 0.3 ms, and a decay time constant of 42.1 ± 2.1 ms. The single-channel conductance estimated by nonstationary fluctuation analysis was 60 ± 5 pS. The amplitudes (46.5 ± 6.4 pA) and 10–90% rise times (18 ± 2.3 ms) of EPSCs evoked from the entorhinal cortex/subiculum border are significantly larger than the same parameters for spontaneous events (paired t-test, P < 0.05, n = 17). Perfusion of 50 μM d(–)-2-amino-5-phosphonopentanoic acid blocked all spontaneous activity and caused a significant baseline current shift of 18.8 ± 3.0 pA, thus identifying a tonic conductance mediated by NMDA receptors. The NR2B antagonist ifenprodil (10 μM) significantly reduced the frequency of spontaneous events but had no effect on their kinetics or on the baseline current or variance. At the same time, the peak current and charge of stimulus-evoked events were significantly diminished by ifenprodil. Thus spontaneous NMDA receptor-mediated events in DGGC are predominantly mediated by NR2A or possibly NR2A/NR2B receptors while the activation of NR2B receptors reduces the excitability of entorhinal afferents either directly or through an effect on the entorhinal cells.